2-218781813-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The ENST00000494263.5(CYP27A1):​n.65T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000366 in 92,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0083 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

CYP27A1
ENST00000494263.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.910

Publications

1 publications found
Variant links:
Genes affected
CYP27A1 (HGNC:2605): (cytochrome P450 family 27 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008]
CYP27A1 Gene-Disease associations (from GenCC):
  • cerebrotendinous xanthomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00826 (26/3148) while in subpopulation AMR AF = 0.0324 (9/278). AF 95% confidence interval is 0.0169. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP27A1ENST00000494263.5 linkn.65T>C non_coding_transcript_exon_variant Exon 1 of 7 2

Frequencies

GnomAD3 genomes
AF:
0.00826
AC:
26
AN:
3146
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00306
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0326
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00795
Gnomad OTH
AF:
0.0313
GnomAD4 exome
AF:
0.0000892
AC:
8
AN:
89652
Hom.:
0
Cov.:
0
AF XY:
0.000154
AC XY:
7
AN XY:
45464
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2298
American (AMR)
AF:
0.00
AC:
0
AN:
2410
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2942
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4980
South Asian (SAS)
AF:
0.00
AC:
0
AN:
6856
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5906
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
456
European-Non Finnish (NFE)
AF:
0.0000862
AC:
5
AN:
58024
Other (OTH)
AF:
0.000519
AC:
3
AN:
5780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00826
AC:
26
AN:
3148
Hom.:
0
Cov.:
31
AF XY:
0.00786
AC XY:
12
AN XY:
1526
show subpopulations
African (AFR)
AF:
0.00306
AC:
2
AN:
654
American (AMR)
AF:
0.0324
AC:
9
AN:
278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
96
South Asian (SAS)
AF:
0.00
AC:
0
AN:
44
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4
European-Non Finnish (NFE)
AF:
0.00795
AC:
14
AN:
1760
Other (OTH)
AF:
0.0313
AC:
1
AN:
32
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000693
Hom.:
0
Bravo
AF:
0.000223

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cholestanol storage disease Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
2.9
DANN
Benign
0.26
PhyloP100
-0.91
PromoterAI
0.038
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182545847; hg19: chr2-219646536; API